Efficacy of subantimicrobial dose of doxycycline in the treatment of acne of moderate severity: a review of international studie

Cover Page

Abstract


The article analyzes the recent data concerning the new trends in the treatment of acne vulgaris of moderate severity using tetracyclines. Low-dose regimen of doxycycline is highly effective against inflammatory and noninflammatory lesions in patients with moderate acne on the face with a minority of side effects.

About the authors

A. A. Khryanin

Novosibirsk State Medical University

Author for correspondence.
Email: khryanin@mail.ru

Russian Federation

O. V. Reshetnikov

Federal State Budgetary Institution of Internal and Preventive Medicine Siberian Branch under the Russian Academy of Medical Sciences

Email: noemail@neicon.ru

Russian Federation

References

  1. Sykes L.S., Webster G.F. Acne. A review of optimum treatment. Drugs 1994; 48: 59-70.
  2. Meynadier J., Alirezai M. Systemic antibiotics for acne. Dermatology 1998; 33б (16): 1156-1162.
  3. Jugeau S., Tenaud I., Knol A.C. Induction of tolllike receptors by Propionibacterium acnes. Br J Dermatol 2005; 153: 1105-1113.
  4. Kozlovskaya V.V., Khaykova E.A. Terapiya akne sredney stepeni tyazhesti s ispol'zovaniem nizkikh doz doksitsiklina (Yunidoksa Solyutab). Meditsinskie novosti 2011; 2: 72-75.
  5. Hayashi N., Akamatsu H., Kawashima M. Acne Study Group. establishment of grading criteria for acne severity. J Dermatol 2008; 35 (5): 255-260.
  6. Kotova N.V., Suvorova K.N. Yunosheskie akne. Moskva: NPF «Nov'» 2002; 54.
  7. Estery N.B., Koransky J.S., Furey N.I., Trevisan M. Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 1984; 120: 1308-1313.
  8. Cunliffe W.J. Evolution of strategy for the treatment of acne. J Am Acad Dermatol 1987; 16: 591-599.
  9. Greenfood R., Burke B., Cunliffe W.J. Evolution of a therapeutic strategy for the treatment of acne vulgaris with conventional therapy. Br J Dermatol 1986; 114: 353-358.
  10. Lever L., Marks R. Current views on the aetiology, pathogenesis and treatment of acne vulgaris. Drugs 1990; 39 (5): 681-692.
  11. Araviyskaya Ye.R., Sokolovsky Ye.V. Systemic antibiotics therapy of acne: certain controversies.Vestnik Dermatologii i Venerologii 2013; 6: 117-121.
  12. Zaenglein A.L., Thiboutot D.M. Expert Committee Recommendations for Acne Management. Pediatrics 2006; 118: 1188-1199.
  13. Thiboutot D., Gollnick H.P., Bettoli V. et al. New insights into the management of acne: An update from the Global Alliance to improve outcomes in acne group. J Am Acad Dermatol 2009; 60 (5 Suppl): S1-S50.
  14. Nast A., Dreno B., Bettoli V. et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol 2012, 26 (Suppl 1): 1-29.
  15. Akne / Pod red. Kubanovoy A. Moskva: DEKS-Press 2010; 28. [Акне / Под ред. А.А. Кубановой. Москва: ДЭКС-Пресс 2010; 28.]
  16. Engebretson S.P., Hey-Hadavi J. Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study. Pharmacol Res 2011; 64 (6): 624-629.
  17. Gu Y., Walker C., Ryan M.E. et al. Non-antibacterial tetracycline formulations: clinical applications in dentistry and medicine. J Oral Microbiol 2012; 4: 10.3402/jom.v4i0.19227.
  18. Golub L.M., Greenwald R.A., Thompson R.W. Tetracycline use and risk of acute myocardial infarction. JAMA 1999; 282: 1997-1998.
  19. Toossi P., Farshchian M., Malekzad F. et al. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol 2008; 7 (12): 1149-1152.
  20. Parish L.C., Parish J.L., Routh H.B., Witkowski J.A. The treatment of acne vulgaris with low dosage doxycycline. Acta Dermatovenerol Croat 2005; 13 (3): 156-159.
  21. Maleszka R., Turek-Urasinska K., Oremus M. et al. Pulsed azithromycin treatment is as effective and safe as 2-week-longer daily doxycycline treatment of acne vulgaris: a randomized, double-blind, noninferiority study. Skinmed 2011; 9 (2): 86-94.
  22. Babaeinejad S., Khodaeiani E., Fouladi R.F. Comparison of therapeutic effects of oral doxycycline and azithromycin in patients with moderate acne vulgaris: what is the role of age? J Dermatolog Treat 2011; 22 (4): 206-210.
  23. Skidmore R., Kovach R., Walker C. et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003; 139 (4): 459-464.
  24. Nast A., Dreno B., Bettoli V. et al. European evidence-based (S3) guidelines for the treatment of acne. JEADV 2012, 26 (Suppl 1): 1-29.
  25. Хрянин А.А. Комплексная патогенетическая терапия акне. Клиничегаий случай. Consilium Medicum 2014; 1: 18-19.
  26. Kleine M.W. Introduction to oral enzyme therapy. Int J Immunotherapy 1997; 13: 59-65.

Statistics

Views

Abstract - 152

PDF (Russian) - 1218

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies